Drug developed using X-rays targets two forms of cancer

A drug developed at the Advanced Photon Source X-ray facility at Argonne National Laboratory works to combat two deadly forms of cancer. The drug, Votrient, was approved in 2009 to fight advanced kidney cancer and then approved in 2012 to also fight soft tissue sarcoma.